Two peptides, two pathways

CJC-1295 is a GHRH analogue. It is modelled on growth-hormone-releasing hormone and is studied for the way it engages the GHRH receptor, the body's own upstream trigger in the growth-hormone axis.

Ipamorelin works from the other side. It is a growth-hormone-releasing peptide (GHRP) that acts as a ghrelin-receptor agonist, reaching the GHS-R receptor rather than the GHRH one. Same axis in the research literature, different door in.

Why they are studied together

Because the two peptides engage separate receptors, researchers study them as complementary signals rather than competitors. CJC-1295 addresses the GHRH side of the axis and Ipamorelin the ghrelin side, so a pairing lets a study observe both entry points at once.

That is the reasoning behind the combined format. Polaris Research supplies CJC-1295 and Ipamorelin as a single research-grade 10mg blend, which is how the two are most often referenced in the literature. Used alone, each isolates one pathway; used together, they are studied for the way the two signals overlap.

How the two compare

The distinction is easiest to hold as a short comparison. Neither peptide replaces the other, and each maps to a slightly different research question.

• CJC-1295A GHRH analogue that engages the GHRH receptor, the upstream side of the axis.
• IpamorelinA selective GHRP and ghrelin-receptor (GHS-R) agonist, studied for minimal cross-talk with other pathways.
• Why pairedTwo receptors, one axis. The pairing lets a study observe both signals together rather than one at a time.
• Used aloneEach isolates a single pathway, which suits a narrower research question.

CJC-1295, with or without DAC

There is one more variable on the CJC-1295 side: the DAC modification. CJC-1295 with DAC (Drug Affinity Complex) is studied for a longer circulating profile, because the DAC element is designed to keep the peptide in play longer than the unmodified version.

Polaris Research stocks CJC-1295 with DAC as a separate 5mg vial for researchers whose question is specifically about that extended profile, alongside the CJC-1295 and Ipamorelin 10mg blend. Which one fits depends on whether the study is about the pairing or about the DAC pharmacokinetics on their own.

Format, purity, and availability

Both formats ship the same way. Every vial from Polaris Research carries an independently verified Certificate of Analysis (≥98% purity) that you can check on the batch verification page using the batch number on the label.

Reconstitute with Bacteriostatic Water added slowly down the wall of the vial, never onto the powder, and swirl rather than shake. The blend and the DAC vial both ship with Free Express Delivery Australia-wide, dispatched within 2 business days of confirmed payment.